In order to evaluate the effect of antagomir-21 in angiogenesis inhibition, we established VEGFR2-luc mouse breast tumor model, in which the expression of luciferase can be driven by VEGFR2 promoter and thus allows us to directly visualize angiogenesis using BLI in vivo. The gene discussed is KDR; the disease is breast neoplasm.